← Open Payments lookup

JESSICA BALVITSCH: Open Payments

NPI 1043316524 · BISMARCK, ND. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$236 in 11 payments from 8 companies in 2025. Trend: 2023 $210 · 2024 $256 · 2025 $236

Food & beverage: $236
CompanyPaymentsAmount
Alkermes, Inc.3$55
Vanda Pharmaceuticals Inc.1$46
Neurocrine BioSciences, Inc.2$32
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$32
Teva Pharmaceuticals USA, Inc.1$20
Sage Therapeutics, LLC1$19
ACADIA Pharmaceuticals Inc1$18
Otsuka America Pharmaceutical, Inc.1$14

Products named: ARISTADA, FANAPT, INGREZZA, CAPLYTA, UZEDY, ZURZUVAE, NUPLAZID, REXULTI.

Industry payments across ND — which companies pay providers there.